• S&P 500: 1,340.38
  • Change: -0.86%
$117.09 -0.69 (-0.59%)
2/10/2012 11:23 AM

Biogen Idec, Inc. (NASDAQ:BIIB)

CAPS Rating: 3 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $117.09 Mkt Cap $28.40B
Open $116.98 P/E Ratio 22.80
Prev. Close $117.78 Div. (Yield) N/A (N/A)
Daily Range $116.44 - $117.99 Volume 370,837
52-Wk Range $65.39 - $123.23 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think BIIB will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

645 Outperform
63 Underperform
 

All-Star Players

203 Outperform
11 Underperform
 

Wall Street

17 Outperform
4 Underperform
 

Top BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

StockDocStan (< 20)
Submitted September 07, 2011

The clear leader in the independent biotechs is NOT likely to stay independent for long. I expect a buyout by Roche or even Pfizer or Merck in the next 6 months.

Add Comment | Reply | Report this Post

NetscribeBiotech (87.63)
Submitted February 19, 2007

Biogen Idec Inc, born in 2003 post the merger of Biogen and Idec Pharmaceuticals, develops, manufactures and commercializes novel therapies. With five approved products viz. Avonex, Rituxan, Tysabr, Amevive, Zevalin and several other products in… More

4 Comments | Reply | Report this Post
BIIB VS S&P 500 (SPY)

Fools bullish on BIIB are also bullish on:

Fools bearish on BIIB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar 2trpop (68.43) Submitted: 2/7/2012 10:05:17 AM : Outperform Start Price: $120.46 BIIB Score: -3.15

This one seems like cheating.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar portefeuille (99.82) Submitted: 12/15/2011 10:56:38 PM : Outperform Start Price: $102.70 BIIB Score: +13.57

There are currently 270 BIIB shares in my "fund" with break-even of around 71.89 USD. http://caps.fool.com/Blogs/fund-trades/678775.

Report this Post Add Comment | Reply | Permalink

Recs

1
Member Avatar StockDocStan (< 20) Submitted: 9/7/2011 10:26:09 AM : Outperform Start Price: $91.91 BIIB Score: +14.42

The clear leader in the independent biotechs is NOT likely to stay independent for long. I expect a buyout by Roche or even Pfizer or Merck in the next 6 months.

Report this Post Add Comment | Reply | Permalink
View All 84 Pitches »

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

TMFBreakerJava

TMFBreakerJava (99.38) Score: +175.58

The PML cases have knocked them down, but Tysabri sales will grow regardless. Also benefits from the fact that Biotech is somewhat disconnected from the current chaos in financial markets and seems like a bit of a safe haven at the moment.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
fwhittlesey 20.42 4/12/2007 Outperform 3Y $43.64 +168.24% -1.24% +169.48 1 Comment
anewday101 86.10 3/5/2007 Outperform 1Y $43.36 +169.97% +3.33% +166.65 0 Comment
tradersinsights 50.61 4/10/2007 Outperform 1Y $44.42 +163.53% -1.77% +165.30 1 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +166.35% +1.18% +165.16 0 Comment
mtung 75.05 3/8/2007 Outperform NS $44.10 +165.44% +1.40% +164.04 0 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +174.27% +10.27% +164.00 1 Comment
apple1jam 83.00 3/6/2007 2/27/2008 Outperform NS $43.94 +166.41% +2.69% +163.72 0 Comment
owen1000 71.49 8/22/2006 Outperform 3Y $42.83 +173.31% +10.11% +163.20 0 Comment
nickysone 56.01 4/9/2007 Outperform 3Y $44.86 +160.95% -1.86% +162.81 1 Comment
mgroeber 71.35 4/9/2007 Outperform NS $44.86 +160.95% -1.86% +162.81 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackZacks 71.08 1/24/2012 Outperform 3M $117.03 -0.38% -0.07% -0.32 1/30/2012 @ $116.58 1 Comment
TrackJimCramer 78.14 1/10/2012 Outperform 3W $114.88 +1.88% +3.87% -1.99 0 Comment
TrackBarclaysCap 93.35 12/9/2011 Outperform NS $113.02 +3.56% +6.52% -2.96 0 Comment
TrackUBS 93.33 9/9/2011 Outperform NS $91.61 +27.76% +13.87% +13.89 0 Comment
TrackOppenheimer 79.36 8/18/2011 Outperform NS $88.45 +32.32% +15.13% +17.19 0 Comment
TrackDeutscheSec 90.39 6/21/2011 Outperform NS $98.72 +18.56% +3.48% +15.08 0 Comment
TrackMPAdvisors 96.21 4/15/2011 Outperform NS $82.43 +41.99% +1.44% +40.55 0 Comment
TrackRBCCapMkts 93.35 2/24/2011 Outperform NS $67.23 +74.09% +2.48% +71.61 0 Comment
TrackOppenheimer 79.36 2/2/2011 Underperform NS $65.28 +35.49% -11.30% -46.80 8/18/2011 @ $88.45 0 Comment
TrackGoldmanSach 71.81 11/5/2010 Underperform 5Y $62.49 +87.29% +9.64% -77.66 1 Comment
TrackStifel 96.17 9/9/2010 Underperform NS $57.23 +104.51% +20.13% -84.37 0 Comment
TrackZacks 71.08 8/19/2010 Outperform 3M $55.06 +6.70% +10.49% -3.78 10/22/2010 @ $58.75 1 Comment
TrackSoleil 95.79 3/9/2010 Outperform NS $57.64 +103.05% +17.73% +85.32 0 Comment
TrackStandpoint 97.08 1/19/2010 Outperform NS $54.29 +15.78% +4.22% +11.56 10/28/2010 @ $62.85 0 Comment
TrackJefferies 84.65 11/3/2009 Outperform NS $42.86 +173.08% +28.81% +144.26 0 Comment
TrackBMOCapital 89.21 10/21/2009 Underperform NS $46.95 +149.29% +21.65% -127.64 0 Comment
TrackLeerinkSwan 88.12 7/14/2009 Outperform NS $46.62 +151.05% +49.11% +101.94 0 Comment
TrackBarclaysCap 93.35 2/9/2009 Underperform NS $51.28 -0.06% +5.97% +6.03 5/20/2009 @ $51.25 0 Comment
TrackBreanMurray 66.84 1/28/2009 Underperform NS $49.10 +138.41% +58.16% -80.26 0 Comment
TrackCanaccord 88.87 12/12/2008 Outperform NS $46.31 +152.77% +57.31% +95.47 0 Comment
TrackRWBaird 90.51 11/3/2008 Outperform NS $44.26 +18.17% -10.72% +28.88 2/6/2009 @ $52.30 0 Comment
TrackCowenandCo 84.14 10/28/2008 Outperform NS $41.88 +179.51% +56.88% +122.64 0 Comment
TrackZacks 71.08 10/13/2008 Outperform 3M $47.13 +8.23% +13.13% -4.90 9/5/2009 @ $51.01 1 Comment
TrackLazardCapit 78.91 9/25/2008 Outperform NS $48.24 +142.66% +15.27% +127.39 0 Comment
TrackStanfordRes 85.28 9/11/2008 Outperform NS $46.55 +151.47% +13.46% +138.01 0 Comment
TrackDodgeCox 93.98 3/31/2008 Outperform NS $61.69 -15.92% -37.13% +21.21 2/5/2009 @ $51.87 1 Comment
TrackBofASec 96.91 1/17/2008 Outperform NS $60.61 +93.14% +1.54% +91.60 0 Comment
TrackBWS 81.54 1/15/2008 Outperform NS $59.11 -7.97% -13.88% +5.91 4/20/2010 @ $54.40 0 Comment
TrackJimCramer 78.14 11/27/2007 Underperform 3W $69.75 +64.70% -9.43% -74.13 1/11/2012 @ $114.88 0 Comment
TrackZacks 71.08 10/24/2007 Underperform 3M $76.72 -27.57% -4.23% +23.34 12/17/2007 @ $55.57 1 Comment
TrackBWS 81.54 10/16/2007 Underperform NS $81.05 -13.86% -5.69% +8.17 11/13/2007 @ $69.82 0 Comment
TrackPiperJaff 89.06 10/16/2007 Underperform NS $81.05 -32.62% -4.44% +28.19 12/13/2007 @ $54.61 0 Comment
TrackDeutscheSec 90.39 10/15/2007 Outperform NS $81.85 -41.56% -40.46% -1.11 6/29/2009 @ $47.83 0 Comment
TrackCreditSuiss 92.66 10/2/2007 Underperform NS $67.11 -17.87% -3.94% +13.93 12/13/2007 @ $55.12 0 Comment
TrackEveillard 96.04 9/30/2007 Outperform NS $66.33 -14.19% -4.17% -10.01 12/31/2007 @ $56.92 1 Comment
TrackEdwardOwens 98.63 9/30/2007 Outperform NS $66.33 +76.48% -7.80% +84.28 5 Comments
TrackIcahn 67.93 9/30/2007 Outperform NS $66.33 +76.48% -7.80% +84.28 4 Comments
TrackUBS 93.33 9/13/2007 Underperform NS $63.54 -33.00% -36.85% -3.84 10/29/2008 @ $42.57 0 Comment
TrackBWS 81.54 3/6/2007 Outperform NS $43.94 +46.97% +6.30% +40.68 8/31/2007 @ $64.58 0 Comment
TrackLehmanBros 86.40 11/20/2006 Outperform NS $51.09 +1.12% +7.13% -6.01 6/26/2007 @ $51.66 0 Comment
TrackJimCramer 78.14 3/2/2006 Outperform 3W $46.36 +50.45% +10.79% +39.67 11/27/2007 @ $69.75 0 Comment

Featured Broker Partners